AMJAD ZUHIER SALEM ALROSAN

Amjad Zuhier Salem Alrosan	Associate Professor
Pharmacology	Pharmacology
Faculty of Pharmaceutical Sciences	Department of Clinical Pharmacy and Pharmacy Practice
amjadz@hu.edu.jo
ORCID ID : 201835902
Office No. : A-435	EXT : 3435

C.V. Document file as PDF:

Ph.D.	The University of Sydney	Australia,2020
Master	Jordan University of Science and Technology	Jordan,2014
Bachelor	Jordan University of Science and Technology	Jordan,2012

A dedicated researcher and Associate Professor of Pharmacology with in-depth research experience and interests in Cancer Biology and Translational Oncology, Molecular and Clinical Pharmacology, and a core mechanistic focus on Protein Regulation and Cell Signaling. My research aims to elucidate complex molecular pathways of chronic diseases, identify novel therapeutic targets, and apply clinical and analytical methodologies to advance patient care. I have a strong track record of publishing scientific work in peer-reviewed international journals, designing laboratory and clinical experiments, conducting advanced statistical analysis, and leading research projects.

1)	Alice P. McCloskey, Adam P. Rathbone, Nicola Vasey, Yincent Tse, Ravi Mistry, Ailsa Pickering, Mohanad Odeh, Amjad Z. Alrosan, Rawan Abudalo, Enaam M. Al Momany, Eman Harahsheh, Emma J. Lim. Evaluating a health education intervention to improve pill swallowing for trainee doctors, nurses, physicians' assistants and pharmacists in Europe, the Middle East and Asia – KidzMed Goes Global. Currents in Pharmacy Teaching and Learning. Volume 18, Issue 10, 2026, 102706, ISSN 1877-1297, https://doi.org/10.1016/j.cptl.2026.102706.
2)	Heilat GB, Alwidyan T, Alrosan AZ, Rataan AO, Alrosan K, Ahmad RB, Al-Kammash KR. Assessing the hepatic and renal parameters of breast cancer patient blood samples before and after chemotherapy. Toxicol Rep. 2026 May 27;16:102283. doi: 10.1016/j.toxrep.2026.102283. PMID: 42255660; PMCID: PMC13242028.
3)	Ghaith B Heilat, Tahani Alwidyan, Amjad Z Alrosan, Aseel O Rataan, Khaled Alrosan, Zuheir R Al Rousan. Understanding breast cancer causes: insights from Jordanian women’s awareness. https://doi.org/10.1080/20565623.2026.2626432.
4)	Aseel O Rataan, Amjad Z Alrosan, Haneen A Amawi, Lana Rababah, Osama Abo Alrob, Ayman T Fazaa. Harnessing Oxidative Stress to Kill Hepatocellular Carcinoma Cancer Cells: The Power of Methylselenic Acid and/or Pharmacological Ascorbate Combination—An In Vitro Study.  https://doi.org/10.1155/adpp/9901780
5)	Alrosan, K., Odeh, M., Alwidyan, T., Alrosan, A. Z., & Madae’en, S. (2025). Knowledge, attitudes, and barriers regarding health promotion of ovarian cancer among community pharmacists in Jordan. Future Science OA, 11(1). https://doi.org/10.1080/20565623.2025.2536386
6)	Madae'en S, Dmour I, Alrosan AZ, Alwidyan T, Alrosan K, Alqhewii T, Alnsairat A, Madain R, Smadi T. Pharmacovigilance in pharmacy education: Students' knowledge, attitude and perception: A cross-sectional study in Jordan. Curr Pharm Teach Learn. 2025 Jul 18;17(11):102442. doi: 10.1016/j.cptl.2025.102442. Epub ahead of print. PMID: 40683065.
7)	Amjad Z. Alrosan, Isra Dmour, Aseel O. Rataan, Ghaith B. Heilat, Khaled Alrosan. Comparative pharmacological analysis of fam-trastuzumab deruxtecan-nxki and sacituzumab govitecan-hziy: Two recently developed chemotherapies in the crucial battle against breast cancer, Toxicology Reports Volume 14, 2025, 102054. ISSN 2214-7500. https://doi.org/10.1016/j.toxrep.2025.102054.
8)	Alrosan K, Alrosan AZ, Heilat GB, Alrousan AF, Gammoh OS, Alqudah A, Madae'En S, and Alrousan MJ: Treatment of ovarian cancer: From the past to the new era (Review). Oncol Lett 30: 384, 2025.
9)	Alrosan, A. Z., Alwidyan, T., Heilat, G. B., Rataan, A. O., & Alrosan, K. (2025). Pre-treatment red cell index and metastasis status as independent predictors of overall survival in Jordanian breast cancer patients receiving chemotherapy. Toxicology Reports, 15, 102077. https://doi.org/10.1016/j.toxrep.2025.102077.
10)	Alrosan, A. Z., Alwidyan, T., Heilat, G. B., Rataan, A. O., Madae’en, S., Alrosan, K. (2025). Knowledge and awareness of breast cancer signs and symptoms among Jordanian women. Future Science OA, 11(1). https://doi.org/10.1080/20565623.2025.2510871
11)	Alrosan, A.Z., Heilat, G.B., Alrosan, K. et al. NEDD4 signaling: a new frontier in the diagnosis and treatment of breast and ovarian cancers. Med Oncol 42, 200 (2025). https://doi.org/10.1007/s12032-025-02751-z
12)	Amjad Z. Alrosan, Enaam M.A. Al Momany, Ghaith B. Heilat, Khaled Alrosan, Amro K. Abu-Safieh, Suhaib A. Khuzaie, Ehab M. Alshalout. The Potential of Pharmacological Intervention Targeting NEDD4 in Glioma Heliyon, Volume 11, Issue 5, 2025, e42996, ISSN 2405-8440. https://doi.org/10.1016/j.heliyon.2025.e42996.
13)	Alrosan, A. Z., Heilat, G. B., Alrosan, K., Aleikish, A. A., Rabbaa, A. N., Shakhatreh, A. M., Alshalout, E. M., & Al Momany, E. M. A. (2024). Autonomic brain functioning and age-related health concerns. Current research in physiology, 7, 100123. https://doi.org/10.1016/j.crphys.2024.100123.
14)	Muna Oqal, Bushra Hijazi, Enaam Al Momany, Abdelrahim Alqudah, Basima A. Almomani, Amjad Z. Alrosan, Areen Alshweiat, Rasha Istaiteyeh, Roaa Alnajjar, Yazeed Bani Younes, Ro'ya Al-karra'ein, Perspective of biopharmaceutics knowledge and practice of pharmacy personnel toward the effect of medication route and medical procedure on nullifying fasting, Saudi Pharmaceutical Journal, Volume 31, Issue 9, 2023, 101747, ISSN 1319-0164, https://doi.org/10.1016/j.jsps.2023.101747.
15)	Alrosan AZ, Heilat GB, Al Subeh ZY, Alrosan K, Alrousan AF, Abu-Safieh AK, Alabdallat NS. The effects of statin therapy on brain tumors, particularly glioma: a review. Anticancer Drugs. 2023 Jul 19. doi: 10.1097/CAD.0000000000001533. Epub ahead of print. PMID: 37466094.
16)	Alrosan, A. Z., Alrosan, K., Heilat, G. B., Alsharedeh, R., Abudalo, R., Oqal, M., Alqudah, A., Elmaghrabi, Y. A."Potential roles of NEDD4 and NEDD4L and their utility as therapeutic targets in high?incidence adult male cancers (Review)". Molecular and Clinical Oncology 19.3 (2023): 68.
16)	Alqudah, A.; Qnais, E.Y.; Wedyan, M.A.; Altaber, S.; Bseiso, Y.; Oqal, M.; AbuDalo, R.; Alrosan, K.; Alrosan, A.Z.; Bani Melhim, S.; Alqudah, M.; Athamneh, R.Y.; Gammouh, O. Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model. Molecules 2023, 28, 502. https://doi.org/10.3390/molecules28020502
17)	Rawan H. Alsharedeh, Nida Alshraiedeh, Rawan Huwaitat, Mamduh Alqatan, Esra' O. Taybeh, Amjad Z. Alrosan, Ghaith B. Heilat. Public perceptions of the COVID-19 Pandemic: A National Cross-sectional Study. Research Journal of Pharmacy and Technology. 2022; 15(9):4119-7. doi: 10.52711/0974-360X.2022.00692
18)	Yang A*, Alrosan AZ*, Sharpe LJ, et al. Regulation of ABCG4 transporter expression by sterols and LXR ligands. Biochimica et Biophysica acta. General Subjects. 2021 Jan;1865(1):129769. DOI: 10.1016/j.bbagen.2020.129769. 
*First-Author contribution
19)	Alrosan, A., Aleidi, S.M., Yang, A., Brown, A.J. and Gelissen, I.C. The Adaptor Protein Alix is Involved in the Interaction Between the Ubiquitin Ligase NEDD4-1 and Its Targets, ABCG1 and ABCG4. Int. J. Mol. Sci. 2019; 20: 2714.

•	Internal Examiner, Master’s Thesis Examination Committee, Potentially Inappropriate Medication Dispensing in Older People in Primary Care: Prevalence, Patterns, and Determinants of Pharmacist Intervention: 
A Prospective Mixed-Methods Study, Faculty of Graduate Studies, The Hashemite University, 18 May 2026.

Sep. 2024 – Present 
Assistant Dean of Accreditation and Quality Assurance, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan

•	Oversee accreditation processes, quality assurance initiatives, and continuous improvement activities across the Faculty.
•	Lead the preparation, writing, review, and organization of documentation submitted to accreditation bodies, particularly the Accreditation Council for Pharmacy Education.
•	Chaired and coordinated ACPE-related committees and contributed to the preparation of the BPharm Self-Study Report.
•	Prepared the first drafts of the Student Handbook, Faculty Handbook, and Quality Assurance Manual, which were approved by the Dean.
•	Prepared the Faculty’s response to the ACPE Preliminary Review Team and contributed to post-evaluation and cumulative progress reports.
•	Served as the lead official responsible for documenting progress against the ACPE Quality Criteria 2026 during the 2025–2026 reporting period.
•	Developed the Faculty KPI table and the Faculty assessment table to monitor assessment activities, findings, improvement actions, responsible parties, timelines, and closure of the quality cycle.
•	Served as Rapporteur of the University Committee for Preparing the Policy for Measurement and Development of Key Performance Indicators.
•	Developed detailed procedural cards for accreditation monitoring, student competency examination follow-up, and the development and approval of new academic programs.
•	Developed and applied evaluation criteria for reviewing the Faculty website and monitoring the completeness of accreditation-related content.
•	Coordinated the classification and activation of institutional surveys supporting quality assurance and accreditation.

 	Current Leadership and Committee Appointments, Faculty of Pharmaceutical Sciences, The Hashemite University:
•	Rapporteur, Accreditation, Quality Assurance and Surveys Committee.
•	Member, Curriculum Committee, Faculty of Pharmaceutical Sciences.
•	Member, Community Pharmacy Field Training Committee.
•	Rapporteur, University Committee for Preparing the Policy for Measurement and Development of 
Key Performance Indicators, contributing to the development of the university-wide KPI Policy, HU-Q-09.
•	Member, Strategic Planning Committee.
•	Member, Alumni Follow-up Committee.

 	Previous University and Faculty Service:
•	Chair, ACPE Committee on Organization and Administration.
•	Chair, ACPE Committee on Staff Resources.
•	Former Member, University Council, representing the Faculty of Pharmaceutical Sciences.
•	Former Member, Faculty Council, representing the Department of Clinical Pharmacy and Pharmacy Practice.
•	Former Member, Scientific Research Committee.
•	Former Rapporteur, Seminars and Scientific Days Committee, responsible for coordinating scientific 
seminars, conferences, and faculty scientific activities.
•	Former Rapporteur, Library Committee, overseeing the preparation and dissemination of  a digital 
educational bulletin, organizing print and electronic references, and ensuring compliance with intellectual 
property requirements.
•	Former Member, Student Activities Committee.
•	Former Member, Student Competency Assessment and Examination Results Analysis Committee.

 	Specialized Academic Committees:
•	Internal Examiner, Master’s Thesis Examination Committee, Potentially Inappropriate Medication Dispensing
 in Older People in Primary Care: Prevalence, Patterns, and Determinants of Pharmacist Intervention: 
A Prospective Mixed-Methods Study, Faculty of Graduate Studies, The Hashemite University, 18 May 2026. 
•	Member, Academic Appointment and Selection Committee, Master’s Program in Clinical Pharmacy and 
Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, 2026.
•	Member, Academic Promotion Review Committee, Department of Clinical Pharmacy and Pharmacy Practice,
The Hashemite University, June 2026.
 	Conference and Scientific-Event Leadership:
•	Chair, Scientific Committee, 1st International Conference, “Exploring New Frontiers in Pharmaceutical 
Sciences,” Faculty of Pharmaceutical Sciences, The Hashemite University, April 2024.
-	Served as a member of the Higher Organizing Committee.
-	Chaired and coordinated the work of the Conference Scientific Committee.
-	Contributed to the preparation and scientific review of the conference program and booklet.
-	Held primary responsibility for the conference website.
-	Moderated one of the conference scientific sessions.
•	Member, Organizing Committee, 2nd Scientific Day of the Faculty of Pharmaceutical Sciences, The 
Hashemite University, May 2025.
•	Participant, 3rd Scientific Day, “Pharmacy: Between Professional Development and Safe Practice,”
Faculty of Pharmaceutical Sciences, The Hashemite University, May 2026.

Mar. 2026 – Present
Associate Professor of Pharmacology, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan

Sep. 2020 – Mar. 2026
Assistant Professor of Pharmacology, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan

•	Conducting and leading independent research projects in cancer biology, molecular pharmacology, and related therapeutic areas.
•	Publishing original research findings in reputable international peer-reviewed journals.
•	Teaching experiences in Physiology, Pathophysiology, Pharmacokinetics, Drug Informatics, and Community Pharmacy Training for pharmacy students.
•	Teaching experiences in Pharmacology for nursing students and General Physiology for medical students.

30.07.2018 – 31.12.2018
Lab demonstrator, School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

•	Teaching experiences in Physiology, Pathophysiology, Pharmacokinetics, Drug Informatics, and Community Pharmacy Training for pharmacy students.
•	Teaching experiences in Pharmacology for nursing students and General Physiology for medical students.

2012 – Present 
Jordan Pharmaceutical Association (JPA).

2018 – 2020
Australian Society for Biochemistry and Molecular Biology (ASBMB).

2019 – 2021
Australia and New Zealand Society for Cell and Developmental Biology (ANZSCDB).

 1) Primary Coordinator: Breast and Ovarian Cancers Awareness Campaign in Sama Al-Rosan/Bani Kinana and within The Hashemite University, collaborating with the Jordanian National Breast Cancer Center.

2) Extracurricular Activity Lead: Collaborated with The Hashemite University library to promote library services to faculty and students.

3)Moderator: 1st International Conference "Exploring New Frontiers in Pharmaceutical Sciences", The Hashemite University (April 2024).

4)Speaker & Organizer: Scientific day to educate females about breast and ovarian cancer signs, symptoms, risk factors, and importance of regular screening. Sama Alrosan, Irbid, Jordan (October 29, 2022).

5)Faculty Trainer: Workshop on pill swallowing (avoiding dysphagia) for students at Hashemite University's Pharmacy Management and Pharmaceutical Care Innovation Center, in collaboration with Liverpool John Moores University/School of Pharmacy (November 29, 2021).

6)Poster presentation: Alrosan A., Aleidi S.M., Yang A., Brown A.J. and Gelissen I.C. The Adaptor Protein Alix is Involved in the Interaction Between the Ubiquitin Ligase NEDD4-1 and Its Targets, ABCG1 and ABCG4. ANZSCDB Annual General Meeting, (2nd-4th Oct, 2019), Adelaide, NSW, Australia.

7)Poster presentation:  Amjad Z. Alrosan, Shereen M. Aleidi, Alryel Yang, Andrew J. Brown, and Ingrid C. Gelissen. The Adaptor Protein Alix is Involved in the Interaction Between the Ubiquitin Ligase NEDD4-1 and Its Targets, ABCG1 and ABCG4. Oral Presentation, (2nd Oct, 2019), Sydney, NSW, Australia.

8)Poster presentation:  Alrosan, A., Aleidi, S.M., Yang, A., Brown, A.J., Gelissen, I.C. Is Alix a cofactor/adaptor for ABCG1/ABCG4 and NEDD4-1?. FMH 2018 Scientific Meeting, (7th Dec, 2018), Sydney, NSW, Australia.

9)Poster presentation: Amjad Z. Alrosan, Shereen M. Aleidi, Alryel Yang, Andrew J. Brown, and Ingrid C. Gelissen. Is Alix a cofactor/adaptor for ABCG1/ABCG4 and NEDD4-1? Postgraduate Conference 2018 (26th -27th Sep. 2018), Sydney, NSW, Australia.

10)Poster presentation: Alrosan, A., Aleidi, S.M., Yang, A., Brown, A.J., Gelissen, I.C. Is Alix a cofactor/adaptor for ABCG1/ABCG4 and NEDD4-1?. ComBio conference, (23rd -26th Sep. 2018), Sydney, NSW, Australia.

AMJAD ZUHIER SALEM ALROSAN

AMJAD ZUHIER SALEM ALROSAN

Welcome to the Hashemite University faculty staff website.